Ad
related to: aml treatments for older patients
Search results
Results from the WOW.Com Content Network
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
Glasdegib, sold under the brand name Daurismo, is a medication for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults older than 75 years or those who have comorbidities that preclude use of intensive induction chemotherapy. [5] [6] [7] It is taken by mouth and is used in combination with low-dose cytarabine. [6]
Venetoclax is also indicated as part of a combination therapy for acute myeloid leukemia (AML). [7] For this purpose it is used with azacitidine, decitabine, or low-dose cytarabine for newly diagnosed adults who are age 75 years or older, or those with other health problems where intensive chemotherapy cannot be used.
Sapacitabine is being evaluated as of March 2016 in three different studies; a Phase III trial for elderly patients with AML (acute myeloid leukemia), a Phase II trial for MDS (myelodysplastic syndromes), and a Phase I trial in combination with seliciclib for cancer treatment including hereditary ovarian and breast cancers. [3]
The drug has concluded phase I clinical trials for acute myeloid leukemia. [5] Interim results were presented in Dec 2014. [6] and published April 2015.[7]Based on interim data from ongoing phase I clinical trials presented at the 57th Annual Meeting of the American Society of Hematology (ASH), researchers at Seattle Genetics have planned a phase III clinical trial to begin in 2016.
A grandmother and her toddler granddaughter are facing cancer at the same time. Alicia Fivecoat, who was recently diagnosed with breast cancer, was getting bloodwork done at MD Anderson Cancer ...
FLAG is a chemotherapy regimen used for relapsed and refractory acute myeloid leukemia (AML). [1] The acronym incorporates the three primary ingredients of the regimen: . Fludarabine: an antimetabolite that, while not active toward AML, increases formation of an active cytarabine metabolite, ara-CTP, in AML cells;
He became a liaison to Liebowitz and would let her know exactly what other kids wanted to play with. The list included Legos, board games, Ninja Turtles toys and Madlibs.
Ad
related to: aml treatments for older patients